The T follicular helper cell is related to better survival and therapeutic outcomes in NSCLC, which may be because the T follicular helper cell serves as a critical physiological source of IL-21 for CD8 T cell infiltrating the tumor [34]. Here, CD8A is linked to neoplasm.